Journal of Diabetes Science and Technology·8 OctThe Case for Evaluating Continuous Glucose Monitoring as a Diagnostic Tool for DiabetesCommentaryContinuous Glucose MonitoringPaper
ADA Scientific Sessions 2026 Abstract·6 JunInternational Comparison of Adjuvant Pharmacotherapy Use in Type 1 Diabetes 2018–2024Study in peoplePopulationsPaper
ADA Scientific Sessions 2026 Abstract·6 JunThe Cardioprotective Effect of Glucagon-Like Peptide 1 Receptor Agonist in a Trial Inspired, and Wider, Population Individuals Living with Type 2 Diabetes: A Target Trial Emulation Study in CPRDStudy in peopleInterventionsPaper
ADA Scientific Sessions 2026 Abstract·5 JunThe Association of Dipeptidyl Peptidase-4 Inhibitors (DPP-4i) with Cardiovascular Outcomes in People with Type 2 Diabetes from the UK Clinical Practice Research Datalink (CPRD)Study in peopleInterventionsPaper
ADA Scientific Sessions 2025 Abstract·13 JunSGLT2 Inhibitors or GLP-1 Receptor Agonists? Development of a Personalized Treatment Algorithm for Individuals with Type 2 DiabetesStudy in peopleBiomarkersPaper
ADA Scientific Sessions 2025 Abstract·13 JunThe Use of Continuous Glucose Monitoring to Diagnose Stage 2 Type 1 DiabetesReviewBiomarkersPaper